A possible role of atrial fibrillation as a risk factor for dementia

E Ettorre1, M Cicerchia, G De Benedetto

  • 1Department of Aging, Sapienza Università di Roma, Umberto I Policlinico di Roma, Roma, Italy.

Insights

Atrial fibrillation (AF) is linked to cognitive decline, particularly in women, and may be a risk factor for Alzheimer's disease (AD) rather than vascular dementia (VaD). This suggests impaired cerebral perfusion may drive AD pathogenesis.

Area of Science:

  • Neurology
  • Cardiology

Background:

  • Atrial fibrillation (AF) is a common condition in the elderly, known to increase the risk of stroke and arterial thromboembolism.
  • Emerging research suggests a potential link between AF and cognitive impairment, prompting investigation into AF as a risk factor for dementia.

Purpose of the Study:

  • To investigate the relationship between atrial fibrillation (AF) and different types of dementia, including vascular dementia (VaD), Alzheimer's disease (AD), and mixed dementia (MD).

Main Methods:

  • The study analyzed 71 patients diagnosed with VaD, AD, or MD, divided into male and female groups.
  • Cognitive function was assessed using the Mini-Mental State Examination (MMSE), Clinical Dementia Rating (CDR), Activities of Daily Living (ADL), and Instrumental Activities of Daily Living (IADL) scales.
  • Statistical analysis explored correlations between AF and cognitive scores, separately for males and females.

Main Results:

  • In females, a significant association was observed between AF and MMSE/CDR scores, indicating a correlation with cognitive impairment.
  • No significant linear relationship was found between AF and ADL/IADL scores in females.
  • In males, no significant linear correlations were identified between AF and any of the cognitive assessment scores (MMSE, CDR, ADL, IADL).
  • Unexpectedly, AF was found to be more frequently associated with AD than VaD, suggesting AF as a potential risk factor for AD.

Conclusions:

  • Atrial fibrillation may play a role in the development of Alzheimer's disease, potentially through mechanisms involving impaired cerebral perfusion.
  • These findings challenge the traditional view of AD risk factors and highlight the importance of cerebrovascular health in neurodegenerative disease.
  • The results suggest that therapies aimed at improving cerebral blood flow may be beneficial for AD patients, offering new avenues for treatment.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...